Press releases prior to August 2023 are from EIP Pharma, Inc., a wholly-owned subsidiary of CervoMed, Inc.

BOSTON, MA – May 11, 2023  – EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, today announced that the Company’s senior management team will present at the JMP Securities Life Sciences Conference on Monday, May 15 at 11:00 a.m. ET.
May 11, 2023